Related Experiment Video
Updated: Mar 18, 2026
05:35
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
1.6K
[Anaemia in the elderly]
Deutsche Medizinische Wochenschrift (1946)
|July 1, 2016
Summary
Mild anemia significantly impacts elderly quality of life and survival. Prompt diagnosis and treatment are crucial, as most anemias in older adults have identifiable and manageable causes.
Area of Science:
- Gerontology
- Hematology
- Internal Medicine
Background:
- Anemia in the elderly is linked to reduced quality of life and survival rates.
- Diagnosing anemia in older adults is complex due to age-related physiological changes and co-existing conditions.
- Over 75% of anemias have specific, treatable causes, necessitating thorough investigation.
Purpose of the Study:
- To highlight the challenges in diagnosing anemia in the elderly.
- To introduce soluble transferrin receptor and hepcidin as valuable diagnostic tools.
- To outline the diagnostic and therapeutic approaches for common anemias in older populations.
Main Methods:
- Review of diagnostic challenges in geriatric anemia.
- Discussion of novel biomarkers like soluble transferrin receptor and hepcidin.
- Outline of standard workup including colonoscopy for iron-deficient anemia (IDA).
Main Results:
- Age-related changes in routine lab parameters limit their diagnostic utility.
- Soluble transferrin receptor and hepcidin offer improved differential diagnosis.
- Gastrointestinal bleeding, often treatable via endoscopy, is the primary cause of IDA in the elderly.
Conclusions:
- Early and comprehensive workup of anemia in the elderly is essential.
- Specific biomarkers aid in differentiating anemia causes in older patients.
- Treatment strategies must be tailored to the underlying cause of anemia, including iron replacement, vitamin supplementation, and addressing chronic conditions.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
344
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
344
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
324
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
324
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
310
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
310
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
309
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
309
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
301
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
301
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
795
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
795